TY - JOUR
T1 - Oleanane-type triterpenoids from Panax stipuleanatus and their anticancer activities
AU - Liang, Chun
AU - Ding, Yan
AU - Nguyen, Huu Tung
AU - Kim, Jeong Ah
AU - Boo, Hye Jin
AU - Kang, Hee Kyoung
AU - Nguyen, Mahn Cuong
AU - Kim, Young Ho
PY - 2010/12/1
Y1 - 2010/12/1
N2 - One newly (1) and 10 known oleanane-type triterpenoids (2-11) were isolated from the methanol extract of Panax stipuleanatus rhizomes. Based on their spectroscopic data, these compounds were identified as spinasaponin A methyl ester (1), pesudoginsenoside RP1 methyl ester (2), spinasaponin A 28-O-glucoside (3), pseudoginsenoside RT1 methyl ester (4), pseudoginsenoside RT1 (5), stipuleanoside R2 methyl ester (6), stipuleanoside R2 (7), araloside A methyl ester (8), 3-O-β-d-glucopyranosyl (1→3)-β-d-glucuronopyranoside-28-O-β- d-glucopyranosyl oleanolic acid methyl ester (9), 3-O-β-d-xylopyranosyl (1→2)-β-d-glucopyranosyl-28-O-β-d-glucopyranosyl oleanolic acid (10), and chikusetsusaponin IVa (11). When the cytotoxic activities of the isolated compounds were evaluated, compound 1 exhibited significant cytotoxic activity with IC50 values of 4.44 and 0.63 μM against HL-60 (leukemia) and HCT-116 (colon cancer) cell lines, respectively. Compound 2 showed potent cytotoxicity with an IC50 of 6.50 μM against HCT-116, whereas it was less cytotoxic against HL-60 (IC50 = 41.45 μM). After HL-60 and HCT-116 were treated with compounds 1 and 2, increased production of apoptotic bodies was observed. Furthermore, compounds 1 and 2 in HCT-116 cells activated intrinsic and extrinsic apoptosis pathways by upregulating DR-5 and Bax, downregulating Bcl-2, activating caspase-9, and cleaving poly-ADP-ribose polymerase (PARP). We also observed the activation of ERK1/2 MAPK by both compounds in the HCT-116 cells. Together, compounds 1 and 2 might induce intrinsic and extrinsic apoptosis pathways through the activation of the ERK1/2 MAPK pathway in HCT-116 colon cancer cells. Structure-activity relationship analysis indicated that a carboxyl group at position-28 is potentially responsible for the cytotoxic effects.
AB - One newly (1) and 10 known oleanane-type triterpenoids (2-11) were isolated from the methanol extract of Panax stipuleanatus rhizomes. Based on their spectroscopic data, these compounds were identified as spinasaponin A methyl ester (1), pesudoginsenoside RP1 methyl ester (2), spinasaponin A 28-O-glucoside (3), pseudoginsenoside RT1 methyl ester (4), pseudoginsenoside RT1 (5), stipuleanoside R2 methyl ester (6), stipuleanoside R2 (7), araloside A methyl ester (8), 3-O-β-d-glucopyranosyl (1→3)-β-d-glucuronopyranoside-28-O-β- d-glucopyranosyl oleanolic acid methyl ester (9), 3-O-β-d-xylopyranosyl (1→2)-β-d-glucopyranosyl-28-O-β-d-glucopyranosyl oleanolic acid (10), and chikusetsusaponin IVa (11). When the cytotoxic activities of the isolated compounds were evaluated, compound 1 exhibited significant cytotoxic activity with IC50 values of 4.44 and 0.63 μM against HL-60 (leukemia) and HCT-116 (colon cancer) cell lines, respectively. Compound 2 showed potent cytotoxicity with an IC50 of 6.50 μM against HCT-116, whereas it was less cytotoxic against HL-60 (IC50 = 41.45 μM). After HL-60 and HCT-116 were treated with compounds 1 and 2, increased production of apoptotic bodies was observed. Furthermore, compounds 1 and 2 in HCT-116 cells activated intrinsic and extrinsic apoptosis pathways by upregulating DR-5 and Bax, downregulating Bcl-2, activating caspase-9, and cleaving poly-ADP-ribose polymerase (PARP). We also observed the activation of ERK1/2 MAPK by both compounds in the HCT-116 cells. Together, compounds 1 and 2 might induce intrinsic and extrinsic apoptosis pathways through the activation of the ERK1/2 MAPK pathway in HCT-116 colon cancer cells. Structure-activity relationship analysis indicated that a carboxyl group at position-28 is potentially responsible for the cytotoxic effects.
KW - Apoptosis
KW - ERK1/2
KW - Oleanane-type triterpenoid
KW - Panax stipuleanatus
UR - http://www.scopus.com/inward/record.url?scp=78149283648&partnerID=8YFLogxK
U2 - 10.1016/j.bmcl.2010.09.074
DO - 10.1016/j.bmcl.2010.09.074
M3 - Article
C2 - 20951582
AN - SCOPUS:78149283648
SN - 0960-894X
VL - 20
SP - 7110
EP - 7115
JO - Bioorganic and Medicinal Chemistry Letters
JF - Bioorganic and Medicinal Chemistry Letters
IS - 23
ER -